GlassScriptPhysician profile
Samy Badawy
NPI 1578625497
$2,502.72
in general payments reported to CMS, 2019-2025
20 companies · $33.35 in 2025
The $33.35 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $427 · 2020: $526 · 2021: $595 · 2022: $872 · 2023: $49.60 · 2025: $33.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $82.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $82.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $766.71 | 2019-2023 | Rinvoq |
| Janssen Biotech, INC. | $629.54 | 2019-2023 | Stelara, Simponi, Remicade |
| Sun Pharmaceutical Industries INC. | $212.46 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $205.17 | 2019-2022 | |
| Genentech USA, INC. | $121.05 | 2019-2022 | |
| Incyte Corporation | $90.42 | 2022 | |
| Novartis Pharmaceuticals Corporation | $85.38 | 2019-2025 | |
| Leo Pharma INC. | $60.90 | 2020-2022 | |
| Epi Health, LLC | $54.69 | 2020 | |
| Amgen INC. | $51.09 | 2020-2022 | |
| Almirall LLC | $45.48 | 2019-2020 | |
| Lilly USA, LLC | $24.80 | 2022 | |
| Dermira, INC. | $24.50 | 2020 | |
| Genzyme Corporation | $23.09 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.17 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sandoz INC. | $20.51 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.64 | 2019 | |
| Biofrontera INC. | $17.34 | 2021 | |
| Helsinn Therapeutics (U.S.), INC. | $16.62 | 2021 | |
| Mission Pharmacal Company | $12.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samy Badawy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.